Analytical Data
-
基因名
C8orf30A
- Application
-
别名
Brain Protein 16; BRP16; C8orf30A; chromosome 8 open reading frame 30A; D15Ertd741e; F203A_HUMAN; Fam203a; Family with sequence similarity 203 member A; FLJ40907; LOC51236; MGC94185; MNCb-5873; Protein FAM203A
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BTY7
-
表达区间
1-390aa
-
氨基酸序列
MGEAGAGAGASGGPEASPEAEVVKLLPFLAPGARADLQAAAVRHVLALTGCGPGRALLAGQAALLQALMELAPASAPARDAARALVNLAADPGLHETLLAADPGLPARLMGRALDPQWPWAEEAAAALANLSREPAPCAALMAALAAAEPADSGLERLVRALCTPGYNARAPLHYLAPLLSNLSQRPAARAFLLDPDRCVVQRLLPLTQYPDSSVRRGGVVGTLRNCCFEHRHHEWLLGPEVDILPFLLLPLAGPEDFSEEEMERLPVDLQYLPPDKQREPDADIRKMLVEAIMLLTATAPGRQQVRDQGAYLILRELHSWEPEPDVRTACEKLIQVLIGDEPERGMENLLEVQVPEDVEQQLQQLDCREQEQLERELAPEPWVERATPT
-
分子量
68.5 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C8orf30A, also known as chromosome 8 open reading frame 30A, is a gene located on chromosome 8 that has garnered attention due to its potential role in various biological processes and diseases. Recent studies have indicated that C8orf30A may be involved in cellular signaling pathways, immune responses, and possibly tumorigenesis, though its precise functions remain largely unexplored. The recombination and expression of C8orf30A as a fusion protein offers a valuable approach to elucidate its functional characteristics, providing insights into its structural properties and interactions with other cellular components. By generating a recombinant C8orf30A protein, researchers aim to investigate its biochemical properties, including stability, post-translational modifications, and binding affinities. This research is crucial to understanding how C8orf30A might contribute to physiological processes and its potential implications in diseases, particularly cancer. The recombinant protein can also serve as a tool for developing therapeutic strategies, as it can be used in high-throughput screening assays to identify small molecules or antibodies that modulate its activity. Furthermore, understanding the expression patterns of C8orf30A in different tissues and under various physiological conditions can provide insights into its functional relevance. Overall, the study of C8orf30A recombinant protein represents a promising avenue for advancing our knowledge of gene function, disease mechanisms, and the development of novel biomedical applications.
